Flutiform fluticasone/formoterol: Phase III started

SkyePharma said Mundipharma began the placebo-controlled, double-blind, international Phase III EFFECT trial to compare 125/5 and 250/10 µg doses of inhaled flutiform twice daily vs. 12 µg inhaled for...